140 related articles for article (PubMed ID: 7719956)
1. Markers of cartilage matrix metabolism in human joint fluid and serum: the effect of exercise.
Roos H; Dahlberg L; Hoerrner LA; Lark MW; Thonar EJ; Shinmei M; Lindqvist U; Lohmander LS
Osteoarthritis Cartilage; 1995 Mar; 3(1):7-14. PubMed ID: 7719956
[TBL] [Abstract][Full Text] [Related]
2. Cartilage metabolism in the injured and uninjured knee of the same patient.
Dahlberg L; Roos H; Saxne T; Heinegård D; Lark MW; Hoerrner LA; Lohmander LS
Ann Rheum Dis; 1994 Dec; 53(12):823-7. PubMed ID: 7864691
[TBL] [Abstract][Full Text] [Related]
3. Longitudinal and cross-sectional variability in markers of joint metabolism in patients with knee pain and articular cartilage abnormalities.
Lohmander LS; Dahlberg L; Eyre D; Lark M; Thonar EJ; Ryd L
Osteoarthritis Cartilage; 1998 Sep; 6(5):351-61. PubMed ID: 10197170
[TBL] [Abstract][Full Text] [Related]
4. Markers of cartilage and synovial metabolism in joint fluid and serum of patients with chondromalacia of the patella.
Väätäinen U; Lohmander LS; Thonar E; Hongisto T; Agren U; Rönkkö S; Jaroma H; Kosma VM; Tammi M; Kiviranta I
Osteoarthritis Cartilage; 1998 Mar; 6(2):115-24. PubMed ID: 9692066
[TBL] [Abstract][Full Text] [Related]
5. A longitudinal study of cartilage matrix metabolism in patients with cruciate ligament rupture--synovial fluid concentrations of aggrecan fragments, stromelysin-1 and tissue inhibitor of metalloproteinase-1.
Dahlberg L; Fridén T; Roos H; Lark MW; Lohmander LS
Br J Rheumatol; 1994 Dec; 33(12):1107-11. PubMed ID: 8000736
[TBL] [Abstract][Full Text] [Related]
6. Significance of the levels of carboxy terminal type II procollagen peptide, chondroitin sulfate isomers, tissue inhibitor of metalloproteinases, and metalloproteinases in osteoarthritis joint fluid.
Shinmei M; Kobayashi T; Yoshihara Y; Samura A
J Rheumatol Suppl; 1995 Feb; 43():78-81. PubMed ID: 7752146
[TBL] [Abstract][Full Text] [Related]
7. Temporal patterns of stromelysin-1, tissue inhibitor, and proteoglycan fragments in human knee joint fluid after injury to the cruciate ligament or meniscus.
Lohmander LS; Roos H; Dahlberg L; Hoerrner LA; Lark MW
J Orthop Res; 1994 Jan; 12(1):21-8. PubMed ID: 8113939
[TBL] [Abstract][Full Text] [Related]
8. Stromelysin, tissue inhibitor of metalloproteinases and proteoglycan fragments in human knee joint fluid after injury.
Lohmander LS; Hoerrner LA; Dahlberg L; Roos H; Björnsson S; Lark MW
J Rheumatol; 1993 Aug; 20(8):1362-8. PubMed ID: 8230020
[TBL] [Abstract][Full Text] [Related]
9. Differential levels of synovial fluid aggrecan aggregate components in experimental osteoarthritis and joint disuse.
Ratcliffe A; Beauvais PJ; Saed-Nejad F
J Orthop Res; 1994 Jul; 12(4):464-73. PubMed ID: 7520485
[TBL] [Abstract][Full Text] [Related]
10. Release of cartilage oligomeric matrix protein (COMP) into joint fluid after knee injury and in osteoarthritis.
Lohmander LS; Saxne T; Heinegård DK
Ann Rheum Dis; 1994 Jan; 53(1):8-13. PubMed ID: 8311563
[TBL] [Abstract][Full Text] [Related]
11. Analysis of cartilage biomarkers in the early phases of canine experimental osteoarthritis.
Matyas JR; Atley L; Ionescu M; Eyre DR; Poole AR
Arthritis Rheum; 2004 Feb; 50(2):543-52. PubMed ID: 14872497
[TBL] [Abstract][Full Text] [Related]
12. Changes in joint cartilage aggrecan after knee injury and in osteoarthritis.
Lohmander LS; Ionescu M; Jugessur H; Poole AR
Arthritis Rheum; 1999 Mar; 42(3):534-44. PubMed ID: 10088777
[TBL] [Abstract][Full Text] [Related]
13. Metalloproteinases, tissue inhibitor, and proteoglycan fragments in knee synovial fluid in human osteoarthritis.
Lohmander LS; Hoerrner LA; Lark MW
Arthritis Rheum; 1993 Feb; 36(2):181-9. PubMed ID: 8431206
[TBL] [Abstract][Full Text] [Related]
14. Markers of joint tissue turnover in joint fluids from hips with osteonecrosis of the femoral head.
Jingushi S; Lohmander LS; Shinmei M; Hoerrner LA; Lark MW; Sugioka Y; Iwamoto Y
J Orthop Res; 2000 Sep; 18(5):728-33. PubMed ID: 11117293
[TBL] [Abstract][Full Text] [Related]
15. Turnover of type II collagen and aggrecan in cartilage matrix at the onset of inflammatory arthritis in humans: relationship to mediators of systemic and local inflammation.
Fraser A; Fearon U; Billinghurst RC; Ionescu M; Reece R; Barwick T; Emery P; Poole AR; Veale DJ
Arthritis Rheum; 2003 Nov; 48(11):3085-95. PubMed ID: 14613270
[TBL] [Abstract][Full Text] [Related]
16. Cartilage and bone macromolecules in knee joint synovial fluid in rheumatoid arthritis: relation to development of knee or hip joint destruction.
Månsson B; Geborek P; Saxne T
Ann Rheum Dis; 1997 Feb; 56(2):91-6. PubMed ID: 9068280
[TBL] [Abstract][Full Text] [Related]
17. Relationships of matrix metalloproteinases and their inhibitors to cartilage proteoglycan and collagen turnover and inflammation as revealed by analyses of synovial fluids from patients with rheumatoid arthritis.
Ishiguro N; Ito T; Oguchi T; Kojima T; Iwata H; Ionescu M; Poole AR
Arthritis Rheum; 2001 Nov; 44(11):2503-11. PubMed ID: 11710706
[TBL] [Abstract][Full Text] [Related]
18. Alterations in cartilage type-II procollagen and aggrecan contents in synovial fluid in equine osteochondrosis.
Laverty S; Ionescu M; Marcoux M; Bouré L; Doizé B; Poole AR
J Orthop Res; 2000 May; 18(3):399-405. PubMed ID: 10937626
[TBL] [Abstract][Full Text] [Related]
19. Changes in cartilage proteoglycan aggrecan after intra-articular injection of interleukin-1 in rabbits: studies of synovial fluid and articular cartilage.
Lundberg C; Asberg I; Ionescu M; Reiner A; Smedegård G; Poole AR
Ann Rheum Dis; 1996 Aug; 55(8):525-34. PubMed ID: 8774180
[TBL] [Abstract][Full Text] [Related]
20. Use of synovial fluid markers of cartilage synthesis and turnover to study effects of repeated intra-articular administration of methylprednisolone acetate on articular cartilage in vivo.
Robion FC; Doizé B; Bouré L; Marcoux M; Ionescu M; Reiner A; Poole AR; Laverty S
J Orthop Res; 2001 Mar; 19(2):250-8. PubMed ID: 11347698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
